Home
News
Tech
Finance
Leadership
Well
Recommends
Fortune 500
Home Page
Already have an account?
SIGN IN
SEARCH
Subscribe Now
Sections
FORTUNE 500
News
Europe
Asia
Tech
AI
Finance
Personal Finance
Real Estate
Crypto
Leadership
Success
Well
Life
Health
Mind
Family
Aging Well
Recommends
Credit Cards
Banking
Best High-Yield Savings Accounts
Best Savings Accounts
Best CD Rates
Best Money Market Accounts
Savings Calculator
Insurance
Mortgages
Investing
Loans
Health
Education
Top Business Schools
Top Information Technology and Data Schools
Top Health Schools
Business Solutions
Video
Rankings
FORTUNE 500
GLOBAL 500
MOST POWERFUL WOMEN
GREAT PLACE TO WORK LISTS
BEST MBA PROGRAMS
MORE RANKINGS
Analytics
Newsletters
Magazine
December 2023/January 2024
October/November 2023
August/September 2023
June/July 2023
April/May 2023
February/March 2023
Live Media
CEO Initiative
Pharmaceutical Industry
Health
Sergey Brin is using money from selling his Tesla shares to bankroll a startup developing hallucinogenic mental-health treatments
BY
Marco Quiroz-Gutierrez
Retail
An obesity pill study tested on just 25 patients led to a stunning $16.8 billion increase in Swiss drugmaker Roche’s market value
BY
Naomi Kresge
,
Lisa Pham
and
Bloomberg
Health
Pharma giant Pfizer is trying to cash in on the weight loss drug craze with a new pill that could be a welcome needle-free alternative to pesky GLP-1 shots
BY
Damian Garde
and
Bloomberg
Commentary
Why investing in places like Birmingham, Alabama is key to securing U.S. biotech dominance as China tries to close the gap
BY
Katie Britt
,
Terri Sewell
,
Kay Ivey
and
Randall Woodfin
Commentary
Alzheimer’s made my mom unable to recognize her grandkids. Breakthroughs too late for her can change the disease’s trajectory—if diagnosis and treatment start early
BY
Anne E. White
Health
Fake Ozempic and Wegovy are flooding the market. Here are 4 steps to avoid dangerous counterfeit weight loss drugs
BY
Amanda Loudin
Tech
Meta axed his AI biology research team. Now this ‘Meta AI mafia’ member’s new startup has $142 million to chase his protein-generating dream
BY
Sharon Goldman
Commentary
‘A head-in-the-sand approach’: The U.S. strategic drug stockpile is inadequate for a bird flu outbreak
BY
Carolyn Barber
Leadership
Forget expensive coaches, Paul Hudson, CEO of Sanofi turns to his three children for advice: ‘Through their eyes I get a glimpse into what the future looks like for the next generation’
BY
Peter Vanham
Retail
Ozempic is 1,300% more expensive in the U.S. vs the U.K.—so the boss of Novo Nordisk is being hauled in front of Bernie Sanders to explain why
BY
Ryan Hogg
Health
Mold colonies and liquid-flooded air purifiers: CVS sourced medication from tainted factories—and it has twice the amount of recalls on store-brand drugs than competitors
BY
Sasha Rogelberg
Politics
Biden’s plan to save money on Medicare drugs risks leaving shelves empty, pharmacists say
BY
Susan Jaffe
and
KFF Health News
Health
Alzheimer’s drug from Eli Lilly that can slow brain-robbing disease backed by FDA advisers
BY
Matthew Perrone
and
The Associated Press
Newsletters
Female CEOs used to run America’s top drugstores. But two powerful women were replaced this year as pharmacies face a national crisis
BY
Maria Aspan
and
Joseph Abrams
Health
‘You’re the smoking cessation counselor, you’re the suicide prevention counselor’—waves of pharmacy closures nationwide take a toll
BY
The Associated Press
,
Tom Murphy
and
Kasturi Pananjady
Load More
Most Popular
Politics
Elon Musk denies reported $45 million a month pledge to Trump, says he doesn’t ‘subscribe to cult of personality’
BY
Eva Roytburg
Finance
Restaurants sit half-empty in Turkey this summer as inflation reaches 91% in places sending tourists and locals...
BY
Taylan Bilgic
and
Bloomberg
Politics
The top Democrats who have not endorsed Kamala Harris all have one thing in common
BY
Eva Roytburg